Catalogue Search | MBRL
Are you sure you want to remove the book from the shelf?
{{itemTitle}}
80,556
result(s) for
"Group therapy"
Sort by:
Geriatric Rehabilitation
As the aging population continues to increase, so does the need for a text specific to the specialized care of the elderly patient as it applies to the physical therapist assistant student, faculty, and clinician.
Geriatric Rehabilitation: A Textbook for the Physical Therapist Assistant
, recognizes the growing role of the PTA in a variety of heath care settings from acute to home to long-term care settings, to name a few.
Inside
Geriatric Rehabilitation
, Dr. Jennifer Bottomley, along with her contributors, focuses on the clinically relevant assessment, treatment, and management of the geriatric population. Pathological manifestations commonly seen in the elderly patient are addressed from a systems perspective, as well as a focus on what is seen clinically and how it affects function.
Each pathological area covered includes:
Screening, assessment, and evaluation
Treatment prescription
Goal setting
Modification of treatment
Anticipated outcomes
Psychosocial, pharmacological, and nutritional elements
The organization and presentation of the practical, hands-on components of interventions, assessments, and decision-making skills make this a go-to text for the PTA to administer comprehensive geriatric care at each point along the continuum of care.
Some of the features inside include:
Emphasis on treatment interventions-techniques, tips, and options
Focus on how assessment tools and treatments are applied and modified to benefit the geriatric population, and what the expected outcomes are
Clear and outlined chapter objectives
User-friendly summary tables in the nutritional and pharmacology chapters
Pearls that highlight important chapter information
Appendices and study aids
Geriatric Rehabilitation: A Textbook for the Physical Therapist Assistant
answers the call for a text that focuses on the management of geriatric patients across the spectrum of care for the PTA, from students to those practicing in geriatric populations.
eBook
Comparing the effectiveness of behavioral activation in group vs. self-help format for reducing depression, repetitive thoughts, and enhancing performance of patients with major depressive disorder: a randomized clinical trial
Background
Behavioral activation has gained increasing attention as an effective treatment for depression. However, the effectiveness of Behavioral Activation Group Therapy (BAGT) in controlled conditions compared to its self-help programs requires more investigation. The present study aimed to compare their effectiveness on depressive symptoms, repetitive negative thinking (RNT), and performance in patients with major depressive disorder (MDD).
Methods
In this randomized clinical trial, 40 patients diagnosed with Major Depressive Disorder (MDD) were recruited based on a structured clinical interview for DSM-5 (SCID-5). Participants were allocated to BAGT (
n
= 20) and self-help behavioral activation (SBA;
n
= 20) groups. BAGT received ten weekly sessions (90 min), while the SBA group followed the same protocol as the self-help intervention. Participants were evaluated at pre-treatment, post-treatment, and the 2-month follow-up using the Beck Depression Inventory-II (BDI-II), repetitive thinking questionnaire (RTQ-31), and work and social adjustment scale (WSAS).
Results
The results of a Mixed ANOVA analysis revealed that participants who underwent BAGT showed significant improvement in depression, rumination, work, and social functioning post-treatment and at the 2-month follow-up. However, the SBA group did not show significant changes in any outcome. The study also found that, based on clinical significance, 68% of the BAGT participants were responsive to treatment, and 31% achieved a high final performance status at the 2-month follow-up.
Discussion
BAGT was more effective than SBA in MDD patients. Participants’ engagement with self-help treatment is discussed.
Trial registration
The present trial has been registered in the Iranian Registry of Clinical Trials Center (IRCT ID: IRCT20181128041782N1||
http://www.irct.ir/
) (Registration Date: 04/03/2019).
Journal Article
G-FORCE: the effectiveness of group psychotherapy for Cluster-C personality disorders: protocol of a pragmatic RCT comparing psychodynamic and two forms of schema group therapy
Background
Cluster-C personality disorders (PDs), characterized by a high level of fear and anxiety, are related to high levels of distress, societal dysfunctioning and chronicity of various mental health disorders. Evidence for the optimal treatment is extremely scarce. Nevertheless, the need to treat these patients is eminent. In clinical practice, group therapy is one of the frequently offered approaches, with two important frameworks: schema therapy and psychodynamic therapy. These two frameworks suggest different mechanisms of change, but until now, this has not yet been explored. The purpose of the present G-FORCE trial is to find evidence on the differential (cost)effectiveness of two forms of schema group therapy and psychodynamic group therapy in the routine clinical setting of an outpatient clinic and to investigate the underlying working mechanisms and predictors of outcome of these therapies.
Methods
In this mono-centre pragmatic randomized clinical trial, 290 patients with Cluster-C PDs or other specified PD with predominantly Cluster-C traits, will be randomized to one of three treatment conditions: group schema therapy for Cluster-C (GST-C, 1 year), schema-focused group therapy (SFGT, 1.5 year) or psychodynamic group therapy (PG, 2 years). Randomization will be pre-stratified on the type of PD. Change in severity of PD (APD-IV) over 24 months will be the primary outcome measure. Secondary outcome measures are personality functioning, psychiatric symptoms and quality of life. Potential predictors and mediators are selected and measured repeatedly. Also, a cost-effectiveness study will be performed, primarily based on a societal perspective, using both clinical effects and quality-adjusted life years. The time-points of assessment are at baseline, start of treatment and after 1, 3, 6, 9, 12, 18, 24 and 36 months.
Discussion
This study is designed to evaluate the effectiveness and cost-effectiveness of three formats of group psychotherapy for Cluster-C PDs. Additionally, predictors, procedure and process variables are analysed to investigate the working mechanisms of the therapies. This is the first large RCT on group therapy for Cluster-C PDs and will contribute improving the care of this neglected patient group. The absence of a control group can be considered as a limitation.
Trial registration
CCMO,
NL72826.029.20
. Registered on 31 August 2020, first participant included on 18 October 2020.
Journal Article
Review of Psychological Interventions in Oncology: Current Trends and Future Directions
Background and Objectives: Cancer imposes a profound burden on both physical and psychological health, particularly at advanced stages, which are associated with a poor prognosis and heightened emotional distress. Psychotherapeutic interventions have gained recognition for their role in alleviating distress, enhancing the quality of life, and supporting a holistic approach to cancer care. This review examines the effectiveness of psychotherapeutic interventions in improving psychological well-being in cancer patients. Materials and Methods: Conducted as a literature review following PRISMA guidelines, this study analyzed experimental research on psychotherapeutic interventions for cancer patients published in the past decade. Literature searches were performed in PubMed, Google Scholar, the Cochrane Library, Web of Science, PsycINFO, and Consensus, supplemented by manual reference checks. The inclusion criteria focused on randomized controlled trials (RCTs). Results: The analysis included 20 RCTs spanning over three decades, evaluating interventions such as individual meaning-centered psychotherapy (IMCP), Mindfulness-Based Cognitive Therapy (MBCT), and supportive–expressive group therapy (SEGT). IMCP emerged as being particularly effective in reducing depression, anxiety, and demoralization while enhancing spiritual well-being. MBCT demonstrated significant reductions in the fear of recurrence, while SEGT effectively addressed traumatic stress and fostered social support. Although the survival benefits were inconsistently reported, psychosocial improvements, including an enhanced quality of life and emotional resilience, were consistently observed. The methodological quality varied, with nine studies meeting high-quality standards. Conclusions: Psychotherapeutic interventions, particularly IMCP and MBCT, play a critical role in oncology by alleviating distress, fostering resilience, and improving the quality of life. Integrating these approaches into routine cancer care can ensure a more holistic treatment framework that prioritizes the emotional and psychological needs of patients.
Journal Article
Effectiveness of adjuvant supportive-expressive group therapy for breast cancer
Purpose
Randomized control trials exploring adjuvant supportive-expressive group therapy (SEGT) for breast cancer have yielded conflicting survival results. This retrospective cohort study was designed to explore the association of adjuvant SEGT performed at diagnosis with survival in real-world patients.
Methods
3327 patients with breast cancer were divided between those who received oncologic treatment combined with SEGT-based intervention (referred to as BRBC [
n
= 354]) and those who only received oncologic treatment (referred to as OT [
n
= 2973]). Primary outcome was overall survival (OS) at 1-year, 3-year, 5-year. Propensity score-matched analysis (at a ratio of 1:3) and instrumental variable analysis (IVA) were performed.
Results
The median overall survival was 7.3 years (95% CI 7.0–7.7 years) in BRBC and 7.1 years (95% CI 6.9–7.4 years) in OT. BRBC was not significantly associated with improved 1-year (HR 0.74, 95% CI 0.49–1.10, P = 0.1748; NNT = 44.8, 95% CI − 118.5 to 22.6), 3-year (HR 0.98, 95% CI 0.75–1.27,
P
= 0.8640; NNT = 273.7, 95% CI − 21.0 to 21.3), or 5-year survival (HR 0.79, 95% CI 0.61–1.02,
P
= 0.0908; NNT = 36.0, 95% CI − 384.5 to 19.1) compared with OT. IVA indicated that BRBC had a survival benefit over OT in the 1-year, 3-year, and 5-year of 1.5% (95% CI 1.2–1.9%), 0.7% (95% CI 0.6–0.8%), and 2.6% (95% CI 2.0–3.4%), respectively.
Conclusion
Adjuvant SEGT cannot significantly prolong 5-year survival in breast cancer, though a longer observation period is warranted according to the marginal survival benefit identified at the end of the follow-up.
Journal Article